Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2

John R. Benson, Ismail Jatoi

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

The 39th annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio, Texas, on 9-13 December 2016. More than 7000 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, locoregional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with Part 1 focusing onmetastatic breast cancer, extended endocrine therapy and the prognostic significance of BRCA1/2 gene mutations. The second part of this report will discuss a range of topics including anti-HER2 directed treatments, the impact of radiotherapy on implant and autologous flap based reconstruction, biological risk predictors for ductal carcinoma-in situ (DCIS), longer term effects of dietary fat modification and the influence of aromatase inhibitors on endothelial cell function.

Original languageEnglish (US)
Article number0089
JournalFuture Oncology
Volume13
Issue number16
DOIs
StatePublished - Jul 2017

Keywords

  • breast conserving surgery
  • extended endocrine therapy
  • mastectomy
  • radiation treatment
  • reconstruction
  • San Antonio

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Highlights of the San Antonio Breast Cancer Symposium 2016: Part 2'. Together they form a unique fingerprint.

  • Cite this